tirzepatide liver damage Histological findings before and after treatment with tirzepatide. (A) Tirzepatide Shows Promise in Fatty

A pragmatic approach is to discontinue semaglutide (35 days) or tirzepatide (2535 days) before conception and liraglutide 3 days prior, transition to safer alternatives such as metformin, and recommend enhanced fetal monitoring in cases of inadvertent exposure

( A ) Schematic of the in vivo animal protocol

Wegovy contains semaglutide, which activates GLP-1 receptors

GLP-1 medications can cause fatigue through several mechanisms including reduced caloric intake due to appetite suppression, gastrointestinal side effects leading to dehydration and electrolyte imbalances, and metabolic adjustment to improved blood glucose control

Always verify the specific beyond-use date on your pharmacy label